heptane-2,4-dione
|
- $65 - $2813
- Product name: heptane-2,4-dione
- CAS: 7307-02-0
- MF: C7H12O2
- MW: 128.17
- EINECS:230-759-5
- MDL Number:MFCD00048722
- Synonyms:heptane-2,4-dione;2,4-HEPTANEDIONE
4 prices
Selected condition:
Brand
- Matrix Scientific
- TRC
Package
- 25mg
- 500mg
- 1g
- 5g
- ManufacturerMatrix Scientific
- Product number189603
- Product descriptionHeptane-2,4-dione
- Packaging500mg
- Price$600
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number189603
- Product descriptionHeptane-2,4-dione
- Packaging1g
- Price$938
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number189603
- Product descriptionHeptane-2,4-dione
- Packaging5g
- Price$2813
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB444148
- Product descriptionheptane-2,4-dione
- Packaging25mg
- Price$65
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Matrix Scientific | 189603 | Heptane-2,4-dione | 500mg | $600 | 2021-12-16 | Buy |
| Matrix Scientific | 189603 | Heptane-2,4-dione | 1g | $938 | 2021-12-16 | Buy |
| Matrix Scientific | 189603 | Heptane-2,4-dione | 5g | $2813 | 2021-12-16 | Buy |
| TRC | B444148 | heptane-2,4-dione | 25mg | $65 | 2021-12-16 | Buy |
Properties
Boiling point :174.05°C (estimate)
Density :0.9805 (rough estimate)
refractive index :1.4500 (estimate)
storage temp. :RT, protect from light
pka :pK1:8.43(keto);9.15(enol) (25°C)
Appearance :Colorless to light yellow Liquid
Density :0.9805 (rough estimate)
refractive index :1.4500 (estimate)
storage temp. :RT, protect from light
pka :pK1:8.43(keto);9.15(enol) (25°C)
Appearance :Colorless to light yellow Liquid
Safety Information
| Symbol(GHS): |
![]()
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|





